Week In Review: Two China Affiliated Biopharmas Raise $585 Million In IPOs
November 06, 2021 at 14:59 PM EDT
LianBio raised $325 million in its Nasdaq IPO at a market capitalization of $1.9 billion to support its drug in-licensings for China. Beijing Clover Biopharma also completed a $260 million IPO in Hong Kong.
